Cargando…

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults

BACKGROUND: Higher circulating fibroblast growth factor 23 (FGF23) associates with greater risk of cardiovascular disease (CVD) and mortality in older adults. The association of FGF23 with cardiovascular outcomes in younger populations has been incompletely explored. METHODS AND RESULTS: We measured...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paul, Shejuti, Wong, Mandy, Akhabue, Ehimare, Mehta, Rupal C., Kramer, Holly, Isakova, Tamara, Carnethon, Mercedes R., Wolf, Myles, Gutiérrez, Orlando M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475041/ https://www.ncbi.nlm.nih.gov/pubmed/34387090 http://dx.doi.org/10.1161/JAHA.120.020196

Ejemplares similares

Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort
por: Sunderraj, Ashwin, et al.
Publicado: (2023)

Association of Educational Attainment With Incidence of CKD in Young Adults
por: Tripathy, Swetapadma, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Leidner, Alexander S., et al.
Publicado: (2023)

Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease
por: Courbon, Guillaume, et al.
Publicado: (2021)

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
por: David, Valentin, et al.
Publicado: (2016)

Disparate Cardiovascular Hospitalization Trends Among Young and Middle‐Aged Adults Within and Across Race and Ethnicity Groups in Four States in the United States
por: Akhabue, Ehimare, et al.
Publicado: (2022)

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
por: Edmonston, Daniel, et al.
Publicado: (2023)

Cefepime-Resistant Pseudomonas aeruginosa
por: Akhabue, Ehimare, et al.
Publicado: (2011)

Chicago supermarket data and food access analytics in census tract shapefiles for 2007–2014
por: Kolak, Marynia, et al.
Publicado: (2018)

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
por: Scialla, Julia J., et al.
Publicado: (2013)

Association of State Medicaid Expansion With Rate of Uninsured Hospitalizations for Major Cardiovascular Events, 2009-2014
por: Akhabue, Ehimare, et al.
Publicado: (2018)

Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study
por: Panwar, Bhupesh, et al.
Publicado: (2016)

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
por: Frazier, Rebecca, et al.
Publicado: (2018)

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)

Racial differences in setting of implantable cardioverter-defibrillator placement in older adults with heart failure and association with disparate post-implant outcomes
por: Akhabue, Ehimare, et al.
Publicado: (2023)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Surge in Delayed Myocardial Infarction Presentations: An Inadvertent Consequence of Social Distancing During the COVID-19 Pandemic
por: Shah, Kulin, et al.
Publicado: (2020)

Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
por: Courbon, Guillaume, et al.
Publicado: (2023)

Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes
por: Marebwa, Barbara K., et al.
Publicado: (2018)

Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults
por: Hanks, Lynae J., et al.
Publicado: (2015)

Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19
por: Sunderraj, Ashwin, et al.
Publicado: (2022)

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
por: Dussold, Corey, et al.
Publicado: (2019)

The role of aldosterone and ideal cardiovascular health in incident diabetes: The Jackson Heart Study
por: Kesireddy, Veena, et al.
Publicado: (2023)

Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers
por: Akhabue, Ehimare, et al.
Publicado: (2017)

The role of aldosterone and ideal cardiovascular health in incident cardiovascular disease: The Jackson heart study
por: Kluwe, Bjorn, et al.
Publicado: (2023)

Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study
por: Drew, David A., et al.
Publicado: (2020)

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019)

Duration and Degree of Weight Gain and Incident Diabetes in Younger Versus Middle-Aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study
por: Wei, Gina S., et al.
Publicado: (2015)

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
por: van der Vaart, Amarens, et al.
Publicado: (2023)

FGF-23: More Than a Regulator of Renal Phosphate Handling?
por: Jüppner, Harald, et al.
Publicado: (2010)

Risk of Incident Heart Failure Among Young Adult Cancer Survivors
por: Hibler, Elizabeth, et al.
Publicado: (2023)

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis
por: Edmonston, Daniel L., et al.
Publicado: (2021)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

Gravidity is not associated with telomere length in a biracial cohort of middle-aged women: The Coronary Artery Risk Development in Young Adults (CARDIA) study
por: Lane-Cordova, Abbi D., et al.
Publicado: (2017)

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort
por: Yeung, Stanley M. H., et al.
Publicado: (2021)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njfjo1dtmtfvvnvk5nl89ko8ob